|
【UCREST 0005 交流专区】(前名 PALETTE)
[复制链接]
|
|
发表于 22-11-2020 10:14 AM
|
显示全部楼层
本帖最后由 icy97 于 6-12-2020 08:35 AM 编辑
SUMMARY OF KEY FINANCIAL INFORMATION
31 May 2020 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 May 2020 | 31 May 2019 | 31 May 2020 | 31 May 2019 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 0 | 2,917 | 12,276 | 28,805 | 2 | Profit/(loss) before tax | -11,882 | -4,064 | -22,498 | 7,098 | 3 | Profit/(loss) for the period | -9,709 | -3,232 | -20,325 | 5,885 | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -9,709 | -3,232 | -20,325 | 5,885 | 5 | Basic earnings/(loss) per share (Subunit) | -2.09 | -0.88 | -4.38 | 1.60 | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0400 | 0.0820
|
|
|
|
|
|
|
|
|
发表于 22-1-2021 09:23 AM
|
显示全部楼层
1. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | Private Placement | Details of corporate proposal | Proposed private placement of up to 20.00% of the total number of issued shares of UCrest | No. of shares issued under this corporate proposal | 25,000,000 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.1223 | Par Value($$) (if applicable) |
| Latest issued share capital after the above corporate proposal in the following | Units | 496,349,875 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 22,840,191.600 | Listing Date | 25 Sep 2020 |
|
|
|
|
|
|
|
|
发表于 27-2-2021 08:50 AM
|
显示全部楼层
Notice of Interest Sub. S-hldr (Section 137 of CA 2016)Particulars of Substantial Securities HolderName | MISS NG GEOK LUI | Nationality/Country of incorporation | Singapore | Descriptions (Class) | Ordinary Shares | Name of registered holder | Ng Geok Lui |
Date interest acquired & no of securities acquired | Date interest acquired | 24 Sep 2020 | No of securities | 25,000,000 | Circumstances by reason of which Securities Holder has interest | Private Placement | Nature of interest | Direct Interest | | Total no of securities after change | Direct (units) | 25,000,000 | Direct (%) | 5.037 | Indirect/deemed interest (units) |
| Indirect/deemed interest (%) |
| Date of notice | 08 Oct 2020 | Date notice received by Listed Issuer | 08 Oct 2020 |
|
|
|
|
|
|
|
|
发表于 17-3-2021 09:21 AM
|
显示全部楼层
1. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | Private Placement | Details of corporate proposal | Proposed private placement of up to 20.00% of the total number of issued shares of UCrest | No. of shares issued under this corporate proposal | 10,600,000 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.1297 | Par Value($$) (if applicable) |
| Latest issued share capital after the above corporate proposal in the following | Units | 506,949,875 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 24,215,011.600 | Listing Date | 27 Oct 2020 |
|
|
|
|
|
|
|
|
发表于 18-3-2021 08:14 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Aug 2020 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 Aug 2020 | 31 Aug 2019 | 31 Aug 2020 | 31 Aug 2019 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 3,275 | 7,514 | 3,275 | 7,514 | 2 | Profit/(loss) before tax | 1,192 | 143 | 1,192 | 143 | 3 | Profit/(loss) for the period | 1,192 | 143 | 1,192 | 143 | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 1,192 | 143 | 1,192 | 143 | 5 | Basic earnings/(loss) per share (Subunit) | 0.25 | 0.03 | 0.25 | 0.03 | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0400 | 0.0400
|
|
|
|
|
|
|
|
|
发表于 19-3-2021 08:55 AM
|
显示全部楼层
本帖最后由 icy97 于 1-8-2021 10:16 AM 编辑
Particulars of substantial Securities HolderName | MISS NG GEOK LUI | Nationality/Country of incorporation | Singapore | Descriptions (Class) | Ordinary Shares | Details of changesNo | Date of change | No of securities | Type of Transaction | Nature of Interest | 1 | 26 Oct 2020 | 10,600,000 | Others | Direct Interest | Name of registered holder | Ng Geok Lui | Description of "Others" Type of Transaction | Private Placement |
Circumstances by reason of which change has occurred | Private Placement | Nature of interest | Direct Interest | Direct (units) | 35,600,000 | Direct (%) | 7.022 | Indirect/deemed interest (units) |
| Indirect/deemed interest (%) |
| Total no of securities after change | 35,600,000 | Date of notice | 27 Oct 2020 | Date notice received by Listed Issuer | 27 Oct 2020 |
Notice of Person Ceasing (Section 139 of CA 2016)Particulars of Substantial Securities HolderName | MISS NG GEOK LUI | Nationality/Country of incorporation | Singapore | Descriptions (Class) | Ordinary Shares | Name of registered holder | Ng Geok Lui | Date of cessation | 08 Dec 2020 |
No of securities disposed | 35,600,000 | Circumstances by reason of which a person ceases to be a substantial shareholder | Disposal in Open Market | Nature of interest | Direct Interest | | Date of notice | 15 Dec 2020 | Date notice received by Listed Issuer | 15 Dec 2020 |
1. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | Private Placement | Details of corporate proposal | Proposed private placement of up to 20.00% of the total number of issued shares of UCrest | No. of shares issued under this corporate proposal | 58,704,575 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.1421 | Par Value($$) (if applicable) |
| Latest issued share capital after the above corporate proposal in the following | Units | 565,827,450 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 32,571,948.110 | Listing Date | 17 Dec 2020 |
Notice of Interest Sub. S-hldr (Section 137 of CA 2016)Particulars of Substantial Securities HolderName | MISS NG GEOK LUI | Nationality/Country of incorporation | Singapore | Descriptions (Class) | Ordinary Shares | Name of registered holder | Ng Geok Lui |
Date interest acquired & no of securities acquired | Date interest acquired | 16 Dec 2020 | No of securities | 58,704,575 | Circumstances by reason of which Securities Holder has interest | Private Placement | Nature of interest | Direct Interest | | Total no of securities after change | Direct (units) | 58,704,575 | Direct (%) | 10.375 | Indirect/deemed interest (units) |
| Indirect/deemed interest (%) |
| Date of notice | 17 Dec 2020 | Date notice received by Listed Issuer | 17 Dec 2020 |
|
|
|
|
|
|
|
|
发表于 14-11-2021 07:39 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Aug 2021 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 Aug 2021 | 31 Aug 2020 | 31 Aug 2021 | 31 Aug 2020 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 7,037 | 3,275 | 7,037 | 3,275 | 2 | Profit/(loss) before tax | -212 | 1,192 | -212 | 1,192 | 3 | Profit/(loss) for the period | -212 | 1,192 | -212 | 1,192 | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -212 | 1,192 | -212 | 1,192 | 5 | Basic earnings/(loss) per share (Subunit) | -0.03 | 0.25 | -0.03 | 0.25 | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.1000 | 0.1000
|
|
|
|
|
|
|
|
|
发表于 20-1-2022 09:20 AM
|
显示全部楼层
Type | Reply to Query | Reply to Bursa Malaysia's Query Letter - Reference ID | IQL-25112021-00002 | Subject | (I) MEMORANDUM OF UNDERSTANDING WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF") (II) MASTER SERVICE AGREEMENT BETWEEN UCREST BERHAD'S ("UCREST") WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED, AND LIMITED LIABILITY COMPANY HUMAN VACCINE, A WHOLLY OWNED SUBSIDIARY OF RDIF | Description | REPLY TO QUERY FROM BURSA MALAYSIA SECURITIES BERHAD ("BURSA SECURITIES") DATED 25 NOVEMBER 2021 PERTAINING TO (I) MEMORANDUM OF UNDERSTANDING WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF") ("MOU") (II) MASTER SERVICE AGREEMENT BETWEEN UCREST BERHAD'S ("UCREST") WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED, AND LIMITED LIABILITY COMPANY HUMAN VACCINE, A WHOLLY OWNED SUBSIDIARY OF RDIF ("MSA") | Query Letter Contents | We refer to your Company’s announcement dated 24 November 2021, in respect of the aforesaid matter.
In this connection, kindly furnish Bursa Securities with the following additional information for public release:- 1) The date on which the Technology Transfer Agreement was entered into.
2) The names of the parties to the Technology Transfer Agreement.
3) The date of approval of the import license and the name of the approving authority.
4) The date on which the Quality Agreement was signed.
5) To clarify whether the Quality Agreement was signed by all 3 contract manufacturers that were announced by UCrest on 19 May 2021 and 9 June 2021. 6) The expected date of commencement of manufacturing of the vaccines. | Please refer to the attachment below for the reply to the query letter from Bursa Malaysia Securities Berhad.
This announcement is dated 26 November 2021.
| https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3213336
|
|
|
|
|
|
|
|
发表于 13-10-2022 09:27 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | UCREST BERHAD ("UCREST" OR "THE COMPANY")- AGREEMENT WITH DOCSUN BIOMED LIMITED | The Board of Directors of UCrest wishes to announce that the Company had on 7 October 2022 signed agreement to invest and to lead the investment of Docsun Biomed Limited (“Docsun”), a holding company that owns a leading US medical technology company that has developed non-contact, non-invasive, non-intrusive vital signs and it has a subsidiary in Taiwan and India. The Company had also on 7 October 2022, signed an Exclusive Distribution Agreement (“EDA”) with Docsun where Docsun is appointed by UCrest as the exclusive distributor for the US market of the iMedic-Docsun integrated products.
Please refer to the attachment for further information. | https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3298582
|
|
|
|
|
|
|
|
发表于 14-3-2024 08:23 PM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | UCREST BERHAD ("UCREST" OR "THE COMPANY")- BUSINESS PARTNERSHIP AGREEMENT WITH MEDIPRIMA HEALTHCARE (M) SDN. BHD. | The Board of Directors of UCrest wishes to announce that the Company had on 14 March 2024 entered into a Business Partnership Agreement ("BPA") with Mediprima Healthcare (M) Sdn. Bhd. (“Mediprima”) to digitalize the clinics with digital health, integrate Artificial Intelligence (“AI”) and Internet of Medical Things (“IoMT”) into the medical services, leading the primary care services to a new era, elevating the healthcare industry to the next level.
Please refer to the attachment for the details of the announcement.
This announcement is dated 14 March 2024.
| https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3430551
|
|
|
|
|
|
|
|
发表于 19-3-2024 03:02 AM
|
显示全部楼层
Type | Reply to Query | Reply to Bursa Malaysia's Query Letter - Reference ID | IQL-15032024-00002 | Subject | UCREST BERHAD (UCREST OR THE COMPANY) - BUSINESS PARTNERSHIP AGREEMENT WITH MEDIPRIMA HEALTHCARE (M) SDN. BHD. (BPA) | Description | UCREST BERHAD ("UCREST" OR "THE COMPANY") - REPLY TO QUERY FROM BURSA MALAYSIA SECURITIES BERHAD ("BURSA SECURITIES") DATED 15 MARCH 2024 PERTAINING TO THE BUSINESS PARTNERSHIP AGREEMENT ("BPA") WITH MEDIPRIMA HEALTHCARE (M) SDN. BHD. | Query Letter Contents | We refer to your Company’s announcement dated 14 March 2024, in respect of the aforesaid matter.
In this connection, kindly furnish Bursa Securities with the following additional information for public release:- 1) The duration of BPA, including its commencement and expiry date.
2) Whether the BPA is renewable, and if so, details of such renewal.
3) The value of the BPA, or the basis for determining the payment to be made to Ucrest.
| We refer to the announcement made by the Company dated 14 March 2024 pertaining to the BPA with Mediprima Healthcare (M) Sdn. Bhd. (“Announcement”) and the query from Bursa Securities dated 15 March 2024 (IQL-15032024-00002) in relation to the Announcement (“Bursa Query”). Unless otherwise stated, the terms used throughout this announcement shall have the same meanings as defined in the Announcement.
Please refer to the attachment for the reply to the query letter from Bursa Securities. | https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3431366
|
|
|
|
|
|
|
|
发表于 21-3-2024 11:05 PM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | UCREST BERHAD ("UCREST" OR "THE COMPANY")- BUSINESS PARTNERSHIP AGREEMENT WITH STAYONLINE LTD | The Board of Directors of UCrest wishes to announce that the Company had on 21 March 2024 entered into a Business Partnership Agreement ("BPA") with StayOnline Ltd (“StayOnline”) to digitalize the healthcare industry with Artificial Intelligence (“AI”) and Internet of Medical Things (“IoMT”) into StayOnline digital payment platform offering intelligent medical services to the population in Rwanda, Kenya, Uganda and Zambia, elevating the healthcare industry to a new era.
Please refer to the attachment for the details of the announcement.
This announcement is dated 21 March 2024. | https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3432354
|
|
|
|
|
|
|
|
发表于 28-3-2024 01:00 PM
|
显示全部楼层
Type | Reply to Query | Reply to Bursa Malaysia's Query Letter - Reference ID | IQL-25032024-00001 | Subject | UCREST BERHAD ("UCREST" OR THE "COMPANY") - BUSINESS PARTNERSHIP AGREEMENT WITH STAYONLINE LTD ("BPA") | Description | UCREST BERHAD ("UCREST" OR "THE COMPANY") - REPLY TO QUERY FROM BURSA MALAYSIA SECURITIES BERHAD ("BURSA SECURITIES") DATED 25 MARCH 2024 PERTAINING TO THE BUSINESS PARTNERSHIP AGREEMENT ("BPA") WITH STAYONLINE LTD | Query Letter Contents | We refer to your Company’s announcement dated 21 March 2024, in respect of the aforesaid matter.
In this connection, kindly furnish Bursa Securities with the following additional information for public release:- 1) Whether the BPA is renewable, and if so, details of such renewal.
2) The value of the BPA, or the basis for determining the payment to be made to Ucrest.
| We refer to the announcement made by the Company dated 21 March 2024 pertaining to the BPA with StayOnline Ltd (“Announcement”) and the query from Bursa Securities dated 25 March 2024 (IQL-25032024-00001) in relation to the Announcement (“Bursa Query”). Unless otherwise stated, the terms used throughout this announcement shall have the same meanings as defined in the Announcement.
Please refer to the attachment for the reply to the query letter from Bursa Securities. | https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3433735
|
|
|
|
|
|
|
|
发表于 4-4-2024 02:12 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | UCREST BERHAD ("UCREST" OR "THE COMPANY")- BUSINESS PARTNERSHIP AGREEMENT WITH MDC ASIA LINK BERHAD | The Board of Directors of UCrest wishes to announce that the Company had on 3 April 2024 entered into a Business Partnership Agreement ("BPA") with MDC Asia Link Berhad (“MDC”) to digitalize with Artificial Intelligence (“AI”) and Internet of Medical Things (“IoMT”) with iMedic™ platform. The objective of the partnership is to take the standard of care in the dental industry to the next level, provide the patients with the highest level of care where MDC will adopt the iMedic™ platform as the Clinic Management System (“CMS”).
Please refer to the attachment for the details of the announcement.
This announcement is dated 3 April 2024.
| https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3435894
|
|
|
|
|
|
|
| |
本周最热论坛帖子
|